BTG acquires Galil Medical for $84.5 million

Michael Walter | | Radiology Business | Economics

British healthcare company BTG has agreed to buy Minnesota-based Galil Medical, a Minnesota-based company that specializes in oncology cryoablation technology, for $84.5 million. Based on various company milestones, BTG could pay up to an additional $25.5 million on top of that initial amount.

“I am very pleased to announce that Galil will be joining the BTG family,” Martin J. Emerson, Galil Medical president and CEO, said in a prepared statement. “Our two companies share a passion for patients and a commitment to innovation that will be better served through this acquisition. Through the significant resources that BTG will bring to bear through this acquisition, I am confident that the acceptance of Galil's market leading cryoablation technology will be accelerated.  We are excited about the opportunity to leverage the BTG market reputation and resources in interventional oncology to become an even more important partner to the global healthcare system.”

The deal is expected to close sometime in the second quarter of 2016. 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers
Congress ditches doc fix in stopgap end-of-year funding bill
Teleradiology provider inks post-acute care deal worth $1.5M annually
US Radiology Specialists affiliate expands into new market
Radiologist rails against insurer’s refusal to cover key interventional service
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.